Cardlytics Inc   (CDLX)
Other Ticker:  
Price: $2.8100 $-0.15 -5.068%
Day's High: $3.1001 Week Perf: -9.94 %
Day's Low: $ 2.61 30 Day Perf: -54.46 %
Volume (M): 1,244 52 Wk High: $ 62.49
Volume (M$): $ 3,495 52 Wk Avg: $15.88
Open: $2.97 52 Wk Low: $2.61

 Market Capitalization (Millions $) 100
 Shares Outstanding (Millions) 36
 Employees 591
 Revenues (TTM) (Millions $) 299
 Net Income (TTM) (Millions $) -465
 Cash Flow (TTM) (Millions $) -112
 Capital Exp. (TTM) (Millions $) 13

Cardlytics Inc
Our objective is to reimagine marketing by putting data to good use. We aim to achieve this goal by running an advertising platform across our and our partners' digital channels, which include the web, mobile apps, email, and different real-time alerts (the "Cardlytics platform"). We also run a consumer data platform that uses point-of-sale ("POS") data, including product-level purchase data, to allow advertisers to do analytics and targeted loyalty marketing while maintaining their privacy, as well as to analyze the impact of their marketing (the "Bridg platform").
The Cardlytics platform's partners are primarily financial institutions ("FI partners") that offer us with anonymised purchase data and access to their digital banking consumers. Merchants ("merchant data partners") who allow us with access to their POS data, including product-level purchase data, are Bridg platform partners. We make purchase data actionable by applying sophisticated analytics to it, assisting marketers in identifying, reaching, and influencing probable buyers at scale, as well as measuring the real sales effect of their marketing expenditure. We work with top marketers in a range of industries, including retail, restaurants, travel and entertainment, direct-to-consumer, and groceries and gas.
Our purchase intelligence, along with our access to customers via our and our partners' digital channels, allows us to assist marketers in resolving basic issues. Marketers increasingly have access to information on their clients' purchasing habits in their own stores, websites, and loyalty programs. They, on the other hand, lack information into their customers' purchasing habits outside of their stores and websites, as well as the buying habits of those who aren't yet their clients. Marketers only observe a small percentage of their consumers' overall purchasing habits, no matter how detailed their own customer data is.
Through the Cardlytics platform, marketers can deliver advertising content to customers in the form of an opportunity to earn rewards, which are funded with a portion of the fees we collect from marketers. Additionally, the Cardlytics platform benefits customers by showing them relevant advertisements tailored to their specific needs based on their spending patterns to enhance their overall experience. We maintain similar platforms in both the United States ("U.S."). and United Kingdom ("U.K.").
The Cardlytics platform helps marketers find potential new customers that are active in their category but not currently shopping with them, or to grow their business with existing customers. Our marketing is targeted and measured based on actual purchase data at a customer and account level. However, all reporting is aggregated across consumers in our network of FI partners. Unlike many other measurement solutions on which the marketing industry has historically relied, our measurements are not probabilistic or based on models, but are based on actual in-store and online purchases.
The breadth of our network of FI partners means that we are able to offer marketers the ability to optimize their marketing efforts to reach a large number of consumers through a single point of contact. The Cardlytics platform also provides our marketers a scalable solution for driving customer loyalty and engagement whereby Cardlytics handles everything from contracting with marketers and creating, managing and reporting performance of their campaigns to attributing incentives to each of our partners' customers.
The Cardlytics platform helps solve fundamental problems for our FI partners. Leveraging our powerful predictive analytics, we create compelling cash back offers that have the potential to drive deeper and sustained use of the FI's digital channels, which we believe reduces customer attrition and increases use of the FIs’ credit and debit cards. Today, our FI partners include Bank of America, National Association ("Bank of America"), JPMorgan Chase Bank, National Association (“Chase”) and Wells Fargo Bank, National Association (“Wells Fargo”), as well as many other national and regional financial institutions, financial technology companies, virtual-only banks, and several of the largest bank processors and digital banking providers to reach customers of small and mid-sized FIs.

   Company Address: 675 Ponce de Leon Ave. NE, Ste 6000 Atlanta 30308 GA
   Company Phone Number: 792-5802   Stock Exchange / Ticker: NASDAQ CDLX
   CDLX is expected to report next financial results on May 01, 2023.

Customers Net Income grew by CDLX's Customers Net Profit Margin grew to

8.09 %

12.49 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


Stock Performances by Major Competitors

5 Days Decrease / Increase
IAC   -1.62%    
META   -0.32%    
SNAP        2.71% 
VMEO        0.56% 
ZIP        1.69% 
DIS        1.63% 
• View Complete Report

Rani Therapeutics Holdings Inc

Underlining the financial span ending December 31 2022 the Major Pharmaceutical Preparations company slipped into deficit at $-0.29 per share, relative to the recent numbers of $0.18 per share a year ago quarter, In the previous quarter the Rani Therapeutics Holdings Inc realized $0.33 per share.

Tyra Biosciences Inc

The company published operating shortfall of $-15.02 millions, in the financial fourth quarter of 2022

While the earnings cycle of fiscal October to December 31 2022 time continues, many corporations have declared their earnings. In the thick of it, have been several constituents of the Major Pharmaceutical Preparations sector. And today, TYRA disclosed operating shortfall of $-15.02 millions, for the financial fourth quarter of 2022.

Assembly Biosciences Inc

In the most recent fiscal period operating shortfall reflected progress to $-62.889 millions, at the Major Pharmaceutical Preparations company

While the earnings season of the October to December 31 2022 period continues, many corporations have disclosed the respective numbers. Among them, have been various businesses in the Major Pharmaceutical Preparations sector. As well as, today, ASMB issued operating shortfall of $-22.978 millions, for the fourth quarter of 2022.

Minerva Surgical Inc

Underlining the financial interval ending December 31 2022 Minerva Surgical Inc Diminishing Returns have swelled at $-0.11 per share, relative to the results of $0.18 per share a year ago reporting period, In the preceding reporting period the Medical Equipment & Supplies company realized $-0.40 per share.

Talis Biomedical Corporation

Redemption of Losses at the Talis Biomedical Corporation during the fiscal fourth quarter of 2022

For the fiscal fourth quarter of 2022 TLIS decreased a loss per share of $-0.97 per share compare to $-1.10 a year ago and EPS improved from $-0.98 per share from the prior financial reporting period.

Sales fell sharply by -78.458 % to $0.26 millions from $1.19 millions in the same financial reporting period a year ago and sequentially Sales Tumbled by -67.714 % from $0.80 millions.


Cardlytics Inc 's Segments
• View Complete Report


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production


Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales


Event Calendar

YEXT's Profile

Stock Price

YEXT's Financials

Business Description


Charts & Quotes

YEXT's News


YEXT's Competitors

Customers & Markets

Economic Indicators

YEXT's Growth

Company Segments


Stock Performance

Growth Rates




Financial Strength


Largest Companies

Management Effectivness


At a Glance


Growth Rates



Financial Strength


At a Glance



Sectors & Industries




At a Glance








About us


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071